Advertisement

Picture Fairtec GmbH We Optimise the ROI of Your Event 600x60px
All >

Deals > Germany

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Germany or involving German organisations.

Total search results: 1438 | Ordered by Date (descending)
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Evotec–Leucadia: investor conference, 201611 supply service Evotec AG presents at Jefferies 2016 Global Healthcare Conference London 2016-11-17
Affimed–Leucadia: investor conference, 201611 supply service Affimed presents at Jefferies 2016 London Healthcare Conference 2016-11-16
Epigenomics–Cathay Fortune: investment, 201611 private placement €2.1m w 474.8k new shares at €4.52/share fully subscribed by Cathay Fortune 2016-11-16
Probiodrug–Leucadia: investor conference, 201611 supply service Probiodrug AG attends Jefferies Global Healthcare Conference London 2016-11-16
Thar Pharmaceuticals–Grünenthal: investment, 201611 acquisition of Thar by Grünenthal 2016-11-16
MorphoSys–BVF Partners: investment, 201611 private placement totalling €115m incl €52.8m from BVF Partners acquiring 1.2m shares at €44/share 2016-11-15
MorphoSys–SEVERAL: investment, 201611 private placement €115m w 2.622m new shares at €44/share to European + North American institutional investors 2016-11-15
Evotec–Oxford Univ: drug discovery, 201611– collab partnership LAB282 for early-stage project out of Oxford Univ with OUI + OSI 2016-11-10
Qiagen–Genohm: LIMS, –201610– collab developm GeneRead Link middleware to connect GeneReader NGS data with LIMS 2016-11-09
CureVac–SEVERAL: investment, 201611 financing $29.5m led by new investors LBBW Asset (for BWVÄZT) + Landeskreditbank BW 2016-11-08
Affimed–Credit Suisse: investor conference, 201611 supply service Affimed presents at Credit Suisse Annual Healthcare Conference 2016-11-07
Epigenomics–SEVERAL: investment, 201611 private placement €5m 1.035m new shares at €4.83/share to UChip Technology Ltd + BioChain (BVI) Inc 2016-11-07
Neovacs–Informa: partnering conference, 201611 supply service Neovacs presents at BIO-Europe 2016 in Cologne 2016-11-07
Takeda–AstraZeneca: digital pathology, 201611– collab using Definiens' newly launched VeriTrova cloud-based solution 2016-11-07
Vaximm–Informa: partnering conference, 201611 supply service Vaximm attends BIO-Europe 2016 in Cologne 2016-11-07
AMP-Therapeutics–EnBiotix: investment, 201611 acquisition of AMPT via asset acquisition by newly established EnBiotix GmbH 2016-11-03
Merck (DE)–BioMed X: pharma research, 201611– collab Merck expansion funding new cancer research groups at BioMed X 2016-11-03
NBE Therapeutics–Boehringer: investment, 201611 financing round Series B CHF20m led by PPF Group wih BIVF + private investors 2016-11-03
Leo Pharma–MorphoSys: therapeutic antibodies, 201611– collab strategic alliance to develop ABs in dermatology using Ylanthia technology 2016-11-02
Calibration Technology (IE)–Eppendorf: investment, 201611 acquisition of CTL by Eppendorf 2016-11-01
Ganymed–Astellas: investment, 201610– acquisition 100% of Ganymed for €422m upfront + €860m milestones by Astellas Pharma Inc 2016-10-28
Ganymed–Freshfields: legal services, 201610 adviser for Ganymed owners for sale of Ganymed to Astellas 2016-10-28
Mologen–Freshfields: legal services, 201610 adviser for capital increase + convertible bond issue 2016-10-28
Cyprotex–Evotec: investment, 201610–201612 acquisition £55.7m=€66.3m in cash for all 26.1m shares + funding of all debt 2016-10-26
Nordic Nanovector–Wilex: antibody-drug conjugates, 201610– collab developm of ADCs for leukemias with Heidelberg Pharma 2016-10-26
Probiodrug–BIO (US): investor conference, 201610 supply service Probiodrug presents at BIO Investor Forum in San Francisco 2016-10-25
Schwabe Pharmaceuticals–ACD/Labs: cheminformatics, 201610– supply deployment of ACD/Spectrus platform by Willmar Schwabe Pharmaceuticals 2016-10-19
Probiodrug–Sofinnova: partnering conference, 201610 supply service Probiodrug presents at Sofinnova Japan Biopharma Partnering Conference in Tokyo 2016-10-18
Max Planck–Labfolder: electronic lab notebook, 201610– supply license for up to 11k MPI researchers using Labfolder s/w 2016-10-12
UgiSense–SEVERAL: investment, 201610 first financing round €1.2m from private investors 2016-10-12
Merck (DE)–HTG: molecular companion diagnostics, 201610– collab master CDx agreement with HTG Molecular Diagnostics 2016-10-11
Probiodrug–SEVERAL: investment, 201610 capital increase €14.9m w 744k new shares at €20/share representing 10% of issued share capital 2016-10-05
Carrick Therapeutics–Evotec: drug discovery services, 201610– collab strategic alliance discovery + preclinical services for novel oncology targets 2016-10-04
Carrick Therapeutics–Evotec: investment, 201610 1st financing round totalling $95m incl up to $6m from co-investor Evotec AG 2016-10-03
Depomed–Grünenthal: pain drug, 201609 collab existent cebranopadol developm + marketing rights for US for Depomed 2016-09-30
Bluebird Bio–Medigene: TCR technology, 201609– collab strategic alliance $15m upfront + up to over $1b funding/milestones + royalties 2016-09-29
Boehringer–ViraTherapeutics: cancer immunotherapy, 201609– long-term collab up to €210m to develop oncolytic virus platform + products 2016-09-28
Immunic–4SC: immune modulatory compounds, 201609 acquisition of small molecule immunology portfolio of 4SC by Immunic 2016-09-28
Immunic–Bavaria (govt): investment, 201609 financing round Series A totalling €17.5m incl co-investor Bayern Kapital 2016-09-27
Immunic–High-Tech Gründerfonds: investment, 201609 financing round Series A totalling €17.5m incl co-investor HTGF 2016-09-27
Immunic–Life Sciences Partners: investment, 201609 financing round Series A totalling €17.5m co-led by LSP V + LifeCare Partners 2016-09-27
Immunic–LifeCare Partners: investment, 201609 financing round Series A totalling €17.5m co-led by LSP V + LifeCare Partners 2016-09-27
Immunic–SEVERAL: investment, 201609 financing round Series A €17.5m co-led by LSP + LifeCare Partners 2016-09-27
Medigene–BIO Deutschland: partnering conference, 201609 supply service Medigene participates in EBDC 2016 in Frankfurt 2016-09-27
NeuRoWeg project–Grünenthal: companion diagnostics, 201609– Grünenthal is partner in project for efficacy tests for neuropathic pain drugs 2016-09-27
NeuRoWeg project–Life & Brain: companion diagnostics, 201609– Life & Brain GmbH is partner in project for efficacy tests for neuropathic pain drugs 2016-09-27
NeuRoWeg project–North Rhine-Westphalia (govt): grant, 201609– EFRD/NRW €1.5m grant to develop test for efficacy of neuropathic pain drugs 2016-09-27
NeuRoWeg project–Univ Bonn: companion diagnostics, 201609– Univ Hospital Bonn is partner in project for efficacy tests for neuropathic pain drugs 2016-09-27
NeuRoWeg project–Univ Cologne: companion diagnostics, 201609– Univ Hospital Cologne partner in project for efficacy tests for neuropathic pain drugs 2016-09-27
Mologen–Global Derivative Trading: credit, 201609– convertible bond with total nominal value of €2.54m by largest investor GDT 2016-09-26
MVZ HZMD Trier–Bruker Corp: mass spectrometer, 201610 supply existent of MALDI Tissuetyper solution 2016-09-25
Evotec–France (govt): cancer drug discovery, 201609– research collab with Inserm in translational oncology 2016-09-22
iOmx Therapeutics–Akampion: public relations, 201609 service existent by Akampion 2016-09-22
iOmx Therapeutics–SEVERAL: investment, 201609 financing round Series A €40m co-led by MPM Capital + Sofinnova Partners 2016-09-22
Lipotype–Germany (govt): grant, 201609 support for Skin Lipidomics developm from Central Innovation Programme for SMEs 2016-09-22
MorphoSys–Baader Bank: investor conference, 201609 supply service MorphoSys presents at Baader Investment Conference 2016 in Munich 2016-09-22
Scienion–Berlin (govt): investment, 201609 DIVESTMENT IBB Beteiligungsgesellschaft sells its shareholding in Scienion AG 2016-09-22
Bayer–Evotec: drug discovery services, 201609– collab 5y €14m minimum + €300m milestones + royalties multi-target research for kidney diseases 2016-09-21
Evotec–Baader Bank: investor conference, 201609 supply service Evotec attends Baader Investment Conference 2016 in Munich 2016-09-21
Evotec–Berenberg: investor conference, 201609 supply service Evotec presents at 5th German Corporate Conference in Munich 2016-09-21
Roche–BioNTech: mRNA technology, 201609– collab ww $310m upfront + near-term milestones + cost-profit-sharing developm mRNA cancer therapies Genentech 2016-09-21
Medigene–Baader Bank: investor conference, 201609 supply service Medigene presents at Baader Investment Conference 2016 in Munich 2016-09-20
MorphoSys–Bank of America: investor conference, 201609 supply service MorphoSys presents at BAML Global Health Care Conference 2016 London 2016-09-15
Organobalance–Novo Group: investment, 201609 acquisition €na of Organobalance GmbH by Novozymes 2016-09-15
Mologen–SEVERAL: investment, 201609–201610 capital increase €13.6m 11.316m common shares at €1.2/share (raising no. of existing shares by up to 50%) 2016-09-13
MorphoSys–JPMorgan Chase: investor conference, 201609 supply service MorphoSys presents at JP Morgan London Small/Mid Cap Conference 2016 2016-09-13
PaxVax–Leukocare: drug formulation technology, 201609– license to SPS technology for one live viral vaccine product of PaxVax 2016-09-13
MorphoSys–Morgan Stanley: investor conference, 201609 supply service MorphoSys presents at Morgan Stanley Global Healthcare Conference NY 2016-09-12
MorphoSys–Goldman Sachs: investor conference, 201609 supply service MorphoSys presents at GS Annual Biotech Symposium in London 2016-09-09
Affimed–Wells Fargo: investor conference, 201609 supply service Affimed presents at Wells Fargo Healthcare Conference in Boston 2016-09-08
Bayer–Helmholtz: plant science, 201609– collab strategic research 5y phenotyping for products by Bayer CropScience + FZJ 2016-09-08
Affimed–Credit Suisse: investor conference, 201609 supply service Affimed presents at Credit Suisse Antibody Day 2016 in New York 2016-09-07
Curetis–Siemens: GEAR database, 201609 acquisition €na of ww rights to GEAR database + related IP + know-how by Curetis from STA 2016-09-07
Biomeva–Asahi Glass: investment, 201609 acquisition 100% of Biomeva GmbH by Asahi Glass 2016-09-06
Rigontec–Boehringer: investment, 201609 financing round Series A 3rd + final closing totalling €15m incl returning investor BIVF 2016-09-06
Rigontec–Forbion: investment, 201609 financing round Series A 3rd + final closing totalling €15m incl returning investor Forbion Capital Partners 2016-09-06
Rigontec–High-Tech Gründerfonds: investment, 201609 financing round Series A 3rd + final closing totalling €15m incl returning investor HTGF 2016-09-06
Rigontec–MacDougall Biomedical Communications: public relations, 201609 service existent by MacDougall 2016-09-06
Rigontec–Mitsubishi Chemical: investment, 201609 financing round Series A 3rd + final closing totalling €15m incl returning investor MP Healthcare 2016-09-06
Rigontec–North Rhine-Westphalia (govt): investment, 201609 financing round Series A 3rd + final closing totalling €15m w returning investor NRW.BANK 2016-09-06
Rigontec–SEVERAL: investment, 201609 financing round Series A 3rd + final closing €15m from existing investors 2016-09-06
Rigontec–Sunstone Capital: investment, 201609 financing round Series A 3rd + final closing totalling €15m incl returning investor Sunstone Capital 2016-09-06
Rigontec–Wellington Partners: investment, 201609 financing round Series A 3rd + final closing totalling €15m incl returning investor Wellington 2016-09-06
DiViNe project–Merck (DE): vaccine purification technology, 201609– collab Merck is partner in Horizon 2020 project led by iBET 2016-09-01
Innovative Medicines Initiative–Lipotype: lipidomics, 201609– collab Lipotype is participant in RHAPSODY project on type 2 diabetes 2016-09-01
Zinsser Analytic–Kohlberg Kravis Roberts: investment, 201609 acquisition of ILS Gmbh + Zinsser Analytic GmbH from Mr+Ms Zinsser by Gardner Denver 2016-09-01
Boehringer–Saniona: schizophrenia drugs, 201608– collab reserach €5m upfront + €85m milestones + royalties to identify compounds for schizophrenia 2016-08-29
Earlybird–SEVERAL: investment, 201608 first closing of Earlybird Health Tech Fund incl investors NRW.Bank + Generali + Miele + BMWE + Barmer GEK 2016-08-24
Ayoxxa–Märzhäuser: microplate reader, 201608 collab developm + contract manufacturing of Ayoxxa Reader AR01 by Märzhäuser 2016-08-22
Mologen–NN: business development services, 201608c– supply service to find outlicensing opportunities for lefitolimod 2016-08-11
Werfen–Protagen: biomarker, 201608– license semi-excl for use of BICD2 biomarker for diagnosis of systemic sclerosis to Inova Diagnostics 2016-08-11
Akvolution–High-Tech Gründerfonds: investment, 201608 financing round Series A incl returning investor HTGF 2016-08-04
Akvolution–SEVERAL: investment, 201608 financing round Series A from HTGF + VNG Innovation + Bamag + private investors 2016-08-04
Oncgnostics–SEVERAL: investment, 201608–201606 crowdfunding campaign €500k via Seedmatch platform 2016-08-04
Applied Micorarrays–Scienion: print/spotting technology, 201607– collab strategic partnership to support developm + production of IVD products 2016-07-28
Merck (DE)–Amoy Diagnostics: molecular diagnostics, 201607– collab developm liquid biopsy RAS biomarker CRC test based on ADx-SuperARMS for China 2016-07-28
Eurofins–Lablicate: mass spectrometry software, 201607 supply existent Eurofins is reference customer for OpenChrom s/w 2016-07-27
Symrise–Lablicate: mass spectrometry software, 201607 supply existent Symrise is reference customer for OpenChrom s/w 2016-07-27
Lophius–SEVERAL: investment, 201607 financing round €4.25m led by VRD GmbH + incl Bayern Kapital + Wolf Biotech + WIC GmbH 2016-07-26
Numares–Bavaria (govt): investment, 201607 financing round incl €2m from Wachstumsfonds Bayern managed by Bayern Kapital 2016-07-26
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15  next pagenext page



Advertisement

Picture BIO Deutschland EBDC 2017 Heidelberg 600x60px

To subscribe to our free, monthly newsletter for the life sciences in German-speaking Europe (DE, AT & CH), please send an e-mail to info@iito.de and simply fill the subject line with the word »LSG newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture Fairtec GmbH We Optimise the ROI of Your Event 600x60px

» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture BCNP Consultants European Chemistry Partnering 2018 Ffm 120x180px Picture BIO Deutschland EBDC 2017 Heidelberg 120x240px Picture EBD Group BioPharm America 2017 BPA Boston MA September 120x180px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture EBD Group BioPharm America 2017 BPA Boston MA September 120x180px Picture BIO Deutschland EBDC 2017 Heidelberg 120x240px Picture BCNP Consultants European Chemistry Partnering 2018 Ffm 120x180px